| Date | Form | Description | Docs | XBRL | Pages |
| 03/31/17 | S-3 | Registration statement for specified transactions by certain issuers |
|
50 | |
| 03/27/17 | RW | Registration Withdrawal Request |
|
1 | |
| 03/16/17 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
31 |
| 03/08/17 | 8-K | Current report filing |
|
34 | |
| 03/06/17 | 424B2 | Prospectus filed pursuant to Rule 424(b)(2) |
|
79 | |
| 02/14/17 | 8-K | Current report filing |
|
6 | |
| 02/01/17 | CT ORDER | Confidential treatment order |
|
1 | |
| 01/27/17 | S-1 | General form of registration statement for all companies including face-amount certificate companies |
|
|
82 |
| 01/19/17 | 8-K | Current report filing |
|
6 | |
| 01/11/17 | 4 | Statement of changes in beneficial ownership of securities |
|
1 |
Latest News & Events
Anixa Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Read More...Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Clinical Trial at the International Gynecologic Cancer Society 2024 Annual Meeting
Read More...Anixa Biosciences Announces FDA Approval of Individual Patient IND for its Ovarian Cancer CAR-T Therapy
Read More...